BSc, MSc, PhD
Clinical Trials Manager
My role involves managing and supporting multiple trials (HABIT, BWEL-B, BARACK-D) within the CTU and also contribute to research publications.
I completed my Masters in Molecular Genetics at the University of Leicester and my PhD in Medical Oncology at the University of Glasgow.
After training and working as an academic researcher, I moved into the field of clinical trials to gain a better understanding on how research impacts people in real life. My experience includes working within the healthcare sector (NHS) across various regions in England.
I have supported and lead on a range of trials (CTIMP, non-CTIMP, device trials; phase 1 to 3, industry-sponsored and non-commercial) in oncology, orthopaedics, gynaecology, gastroenterology, wilderness medicine, cardiology, infectious diseases etc, both nationally within the UK and internationally in Europe, USA and Japan.
I manage and support various trials within the CTU some of which are listed below:
-> Health professional Administered Brief Insomnia Therapy (HABIT) trial. It is a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy (SRT) for insomnia disorder to sleep hygiene (SH) in primary care.
-> A Brief GP Intervention for Weight Loss - Birmingham (BWEL- B).
-> Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK-D)
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of Neoplasia
(2014), Genes and Development, 28, 2712 - 2725
Lysosome-mediated processing of chromatin in senescence
(2013), Journal of Cell Biology, 202, 129 - 143
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
(2011), Molecular Cell, 42, 36 - 49